Organisation paid for research Program year 2024 Source: CMS Open Payments

Pharmaceutical Research and Consult Inc

Neither a doctor nor a teaching hospital

Research payments

$45,458

26 payments

Through program year 2024, Pharmaceutical Research and Consult Inc is reported as receiving $45,458 in research payments, across 26 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$15,615	6
2023	Research	$3,450	1
2022	Research	$75	1
2021	Research	$20,659	16
2020	Research	$5,659	2

Breakdown

Who paid Research payments · program years 2020–2024

Sanofi US Services Inc. $45,458 26 payments

Studies the money was for Research payments · program years 2020–2024

Master Protocol of Two Randomized, Double-blind, Placebo Controlled, Multi-center, Parallel-group Studies of Dupilumab in Patients With Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite the Use of H1 Antihistamine Treatment in Patients naive to Omalizumab and in Patients Who Are Intolerant or Incomplete Responders to Omalizumab $45,458 26 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.